Fortrea Holdings (FTRE) Cash from Operations (2022 - 2026)
Fortrea Holdings (FTRE) reported Cash from Operations of 17000000.0 for Q1 2026, up 86.31% on a YoY basis from 9124459.81 in Q1 2025, and down 113.17% quarter-over-quarter from 129100000.0 in Q4 2025.
Fortrea Holdings (FTRE) Cash from Operations (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Cash from Operations for 5 years, with the latest figure at 17000000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations rose 86.31% year-over-year to 17000000.0; the trailing twelve-month figure through Mar 2026 stood at 220700000.0 (up 34.41% YoY), and the FY2025 full-year result was 113500000.0, down 56.81% from the prior year.
- Cash from Operations for Q1 2026 stood at 17000000.0, down from 129100000.0 in the prior quarter.
- The five-year high for Cash from Operations was 273700000.0 in Q2 2024, with the low at 124200000.0 in Q1 2025.
- Historically, Cash from Operations has averaged 42140000.0 across 5 years, with a median of 18400000.0 in 2023.
- Annual changes were most pronounced in 2024 — Cash from Operations sank 1180.0% — and 2025, when it surged 3716.67%.
- Fortrea Holdings' Cash from Operations stood at 23500000.0 in 2022, then fell by 21.7% to 18400000.0 in 2023, then decreased by 7.07% to 17100000.0 in 2024, then surged by 654.97% to 129100000.0 in 2025, then tumbled by 113.17% to 17000000.0 in 2026.
- The last three Cash from Operations figures came in at 17000000.0 (Q1 2026), 129100000.0 (Q4 2025), and 86800000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | -17.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.00 Mn |
| Mar 31, 2026 | -17.00 Mn |
| Dec 31, 2025 | 129.10 Mn |
| Dec 31, 2025 | 129.10 Mn |
| Sep 30, 2025 | 86.80 Mn |
| Sep 30, 2025 | 86.80 Mn |
| Jun 30, 2025 | 21.80 Mn |
| Jun 30, 2025 | 21.80 Mn |
| Mar 31, 2025 | -124.20 Mn |
| Mar 31, 2025 | -124.20 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Sep 30, 2024 | -2.40 Mn |
| Jun 30, 2024 | 273.70 Mn |
| Jun 30, 2024 | 273.70 Mn |
| Mar 31, 2024 | -25.60 Mn |
| Mar 31, 2024 | -25.60 Mn |
| Dec 31, 2023 | 18.40 Mn |
| Dec 31, 2023 | 18.40 Mn |